Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
GAO reports on transparency of federal agencies. FDA Science Board to meet in February. More regulatory news.
You may also be interested in...
With Transition To IMDRF, Focus Shifts To Convergence On Discrete Regulatory Practices
While the goal of global regulatory harmonization remains the same, the approach has changed. This time, working groups will focus on practical regulatory issues that will not require country-level legislative changes to implement.
FDA Scientific Capacity Inadequate; New Device Technology At Risk
CDRH is not equipped to understand the science behind many cutting-edge device technologies, says a Nov. 29 report from the Subcommittee on Science and Technology, an ad hoc panel of the FDA Science Board
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”